NEWSROOM
Discover all the actions carried out by Jeito and all the partnerships that we set up day after day for the well-being of patients and medical progress.
In the headlines
Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health
Proceeds from the financing will advance ReproNovo’s lead candidates RPN-001 (leflutrozole) and RPN-002 (nolasiban), through Phase 2 clinical trials in male infertility and in the treatment of adenomyosis and embryo implantation, respectively. In the context of...
Download our White Paper
We are pleased to share with you our White Paper, which offers a deep dive into the evolving biopharma landscape and highlights the key trends shaping its future.
Find all our press releases
Jeito Capital becomes Key Player in the Financing of Life Sciences in Europe with the Closing of Jeito I at €534 million ($630 million)
Oversubscribed Jeito I becomes the largest European fund dedicatedto the life sciences sector....
Jeito Capital’s Dr. Rafaèle Tordjman Appointed to Promote the French Biotech Ecosystem
The appointment of Dr. Tordjman was granted by French Ministers, Agnès Pannier-Runacher and...
Jeito Capital becomes key investor in Alentis Therapeutics as part of $67 million Series B financing round
Jeito Capital selects Alentis Therapeutics as its fifth investment since launching the fund...
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide
Jeito selects Pulmocide as its fourth investment since launching the fund Pulmocide is a...
First Year-in-Review: Jeito Capital confirms strength of its investment model and 2021 ambitions with more deals and significant capital
The investment fund confirms the strength of its investment model in medical innovation, closing...
Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and leader in rare skeletal disorders
Jeito’s third international investment in H2 2020, with deep and rapidly accelerating pipeline...
Face to face
Meet Jeito
12-15
January
All day long
JPM Healthcare Conference 2026
Jeito will be present at the 44th JPM Healthcare Conference 2026, renowned as the largest and most influential healthcare investment symposium, attracting global industry leaders, Biotech companies, and members of the investment community, in San Francisco.